Your browser is no longer supported. Please, upgrade your browser.
Settings
VRCA Verrica Pharmaceuticals Inc. daily Stock Chart
VRCA [NASD]
Verrica Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.32 Insider Own33.30% Shs Outstand24.97M Perf Week2.08%
Market Cap210.84M Forward P/E- EPS next Y-1.90 Insider Trans3.12% Shs Float9.77M Perf Month-1.30%
Income-33.00M PEG- EPS next Q-0.43 Inst Own34.40% Short Float26.11% Perf Quarter18.41%
Sales- P/S- EPS this Y-41.60% Inst Trans-0.41% Short Ratio12.28 Perf Half Y-27.37%
Book/sh1.94 P/B4.31 EPS next Y-21.00% ROA-40.40% Target Price- Perf Year-40.16%
Cash/sh3.16 P/C2.65 EPS next 5Y- ROE-54.50% 52W Range6.02 - 18.67 Perf YTD-47.39%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-55.22% Beta-
Dividend %- Quick Ratio2.20 Sales past 5Y- Gross Margin- 52W Low38.87% ATR0.59
Employees17 Current Ratio2.20 Sales Q/Q- Oper. Margin- RSI (14)47.33 Volatility7.10% 7.12%
OptionableNo Debt/Eq0.72 EPS Q/Q-33.90% Profit Margin- Rel Volume0.27 Prev Close8.38
ShortableYes LT Debt/Eq0.00 EarningsAug 05 BMO Payout- Avg Volume207.65K Price8.36
Recom1.80 SMA200.31% SMA50-1.09% SMA200-21.95% Volume55,267 Change-0.24%
Jul-15-20Downgrade BofA Securities Buy → Neutral
Jun-30-20Reiterated H.C. Wainwright Buy $24 → $18
Jun-24-20Initiated Northland Capital Outperform $21
Mar-24-20Initiated Needham Buy $20
Feb-21-19Initiated H.C. Wainwright Buy $20
Sep-23-20 04:05PM  
Sep-22-20 08:30AM  
Sep-14-20 09:36PM  
02:00PM  
01:25PM  
11:00AM  
09:00AM  
01:00AM  
Sep-13-20 01:00PM  
Sep-11-20 02:05PM  
01:00PM  
12:30PM  
10:06AM  
Sep-10-20 01:00PM  
12:30PM  
09:30AM  
Sep-09-20 07:00PM  
01:20PM  
11:00AM  
11:00AM  
09:43AM  
07:30AM  
Sep-08-20 10:30PM  
03:20PM  
01:00PM  
11:36AM  
10:44AM  
09:49AM  
Sep-07-20 04:02PM  
Sep-06-20 10:56PM  
Sep-04-20 11:15AM  
Sep-03-20 09:40PM  
11:00AM  
Sep-02-20 05:20PM  
02:23PM  
02:00PM  
Sep-01-20 11:45PM  
03:45PM  
Aug-31-20 12:27PM  
11:30AM  
Aug-29-20 02:37PM  
Aug-28-20 08:30PM  
Aug-27-20 09:55PM  
12:30PM  
Aug-26-20 03:00PM  
10:00AM  
Aug-25-20 09:46PM  
07:10PM  
01:01PM  
Aug-24-20 03:35PM  
12:00PM  
Aug-22-20 11:03AM  
10:15AM  
Aug-20-20 04:45PM  
01:00PM  
Aug-19-20 05:00PM  
11:36AM  
11:00AM  
Aug-18-20 11:45AM  
Aug-17-20 08:40PM  
Aug-13-20 05:20PM  
12:00PM  
Aug-12-20 04:10PM  
11:30AM  
Aug-11-20 07:00PM  
07:00AM  
Aug-08-20 11:00PM  
Aug-05-20 11:05PM  
07:01AM  
07:00AM  
Aug-04-20 06:00PM  
04:01PM  
11:42AM  
10:00AM  
Aug-03-20 05:35PM  
12:00PM  
Aug-02-20 12:45PM  
Aug-01-20 07:10PM  
Jul-31-20 01:35PM  
Jul-30-20 12:00PM  
11:30AM  
Jul-29-20 10:40PM  
12:23PM  
Jul-25-20 02:34PM  
Jul-24-20 01:00PM  
Jul-23-20 11:15AM  
07:31AM  
07:30AM  
Jul-22-20 07:55PM  
01:00PM  
11:00AM  
Jul-21-20 02:40PM  
12:00PM  
09:42AM  
Jul-20-20 01:30PM  
12:00PM  
11:14AM  
09:34AM  
08:00AM  
Jul-18-20 03:40PM  
Verrica Pharmaceuticals Inc., a clinical stage medical dermatology company, develops and commercializes dermatological treatments in the United States. The company's lead product candidate include VP-102 that is in phase III clinical trial for the treatment of molluscum contagiosum; in phase II clinical trial for the treatment of common warts; and completed phase I clinical trial for the treatment of Genital warts. It is also developing cantharidin-based product candidate, VP-103 for the treatment of plantar warts. The company has a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatologic oncology indications. Verrica Pharmaceuticals Inc. was founded in 2013 and is headquartered in West Chester, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ballaron CraigDirectorAug 25Buy8.574,77240,89610,000Aug 26 04:40 PM
Ballaron CraigDirectorAug 24Buy9.165,22847,8885,228Aug 26 04:40 PM
Manning Paul BDirectorAug 20Buy9.0920,000181,8008,099,394Aug 21 07:44 AM
Manning Paul BDirectorAug 18Buy8.5510,00085,5001,481,719Aug 19 08:40 AM
Manning Paul BDirectorAug 17Buy6.926,00041,5201,471,719Aug 18 08:35 AM
Stalfort SeanDirectorAug 14Buy6.3815,700100,166462,110Aug 17 04:39 PM
Manning Paul BDirectorAug 14Buy6.5150,000325,5001,465,719Aug 17 09:30 AM
Manning Paul BDirectorAug 13Buy6.41108,500695,4851,415,719Aug 17 09:30 AM
Stalfort SeanDirectorAug 13Buy6.4515,550100,298446,410Aug 17 04:39 PM
DAVIS A BRIANChief Financial OfficerAug 13Buy6.247,90049,2967,900Aug 17 04:38 PM
White TedPresident and CEOAug 13Buy6.2810,66166,95117,966Aug 17 04:37 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.